Go to the list of all blogs
published in Blogs
Jul 17, 2026
Ford Motor Company (F) Holds Near $14 After +3% Monthly Gain Amid Volatility

Ford Motor Company (F) Holds Near $14 After +3% Monthly Gain Amid Volatility

Key Takeaways

  • Ford shares rose roughly 3% over the past 30 days, stabilizing near $14 after a turbulent May–June period that saw the stock surge more than 40% and then shed roughly 20%.
  • The May rally was fueled by the launch of Ford Energy, a battery energy storage systems (BESS) division targeting AI data centers and utilities, while June's pullback reflected weak vehicle sales and a large recall.
  • Ford's Q1 2026 results handily beat expectations, with adjusted EBIT of $3.5 billion, and management raised full-year adjusted EBIT guidance to $8.5–$10.5 billion.
  • The restart of aluminum supplier Novelis's Oswego plant removes a critical bottleneck for F-Series truck production, with management expecting about $1 billion in EBIT recovery through the second half of 2026.
  • Ford's Q2 2026 earnings, scheduled for July 28, are widely viewed as the next major catalyst that could define the stock's direction.

Current Market Snapshot

Ford Motor Company (F) shares have settled into a holding pattern after one of the most volatile stretches in recent memory. The stock rocketed to a 52-week high of $17.78 in late May as Wall Street embraced the newly announced Ford Energy business, only to tumble back toward $13.36 by early July after disappointing May sales figures and a recall covering over 740,000 vehicles punctured the enthusiasm. As of mid-July, the stock trades near $14.38, reflecting a modest recovery from June lows. With a forward P/E ratio of approximately 8x and a dividend yield above 4%, the valuation remains compressed relative to the broader market, reflecting persistent skepticism about automotive demand, EV profitability, and warranty-related cost overhangs. One thing that stands out here is how the compressed multiple leaves room for upside if execution improves.

Ford Motor Company (F) Business Overview and Competitive Position

Ford Motor Company (F), headquartered in Dearborn, Michigan, is one of the world's largest automakers, designing and selling a broad lineup of trucks, SUVs, commercial vans, and passenger cars under the Ford and Lincoln brands. The company operates through three primary business segments: Ford Blue (traditional internal combustion engine and hybrid vehicles), Ford Model e (electric vehicles), and Ford Pro (commercial fleet solutions, including software subscriptions and services). Ford's F-Series pickup truck line has been America's best-selling vehicle for over four decades and is estimated by Wall Street analysts to generate as much as 90% of the company's net profit. The company also operates Ford Credit, its captive finance arm, and recently launched Ford Energy, a battery energy storage division targeting the rapidly growing AI data center and utility-scale storage markets. Ford's competitive moat rests on its dominant truck franchise, an expanding software ecosystem with nearly 880,000 paid subscriptions, and one of the strongest balance sheets in the auto industry with over $43 billion in total liquidity. From what I see, the combination of the truck franchise and software growth provides a solid foundation even as EV transitions continue.

Recent Developments Driving F

Several significant developments have shaped Ford's narrative in recent weeks. On the supply-chain front, Novelis restarted production at its Oswego, New York aluminum facility in June after months of outage caused by two fires. The disruption had cost Ford an estimated 100,000 units of lost truck production and up to $2 billion in EBIT impact, so the restart directly addresses one of the company's most painful headwinds. I also checked this using Tickeron’s AI Screener to see how supply-chain recovery compares across the industry.

On the labor front, Ford reached a tentative three-year agreement with Unifor covering more than 5,000 Canadian workers, removing strike risk well ahead of the September contract expiration. Separately, Ford signed a long-term memory-chip supply agreement with Micron Technology (MU), strengthening its semiconductor supply chain for next-generation vehicles.

In quality metrics, Ford earned the top ranking among mainstream brands in the J.D. Power 2026 U.S. Initial Quality Study — its first such win since 2010 — reinforcing management's claim that warranty costs are on a downward trajectory. The company says it is on track for $1 billion in material and warranty cost reductions in 2026.

However, sales figures have softened. Ford reported a 10.3% year-over-year decline in Q2 U.S. vehicle sales, driven largely by constrained F-150 inventory. EV sales fell 40.7% during the quarter, while even hybrids — previously a bright spot — saw double-digit declines. Analyst sentiment remains mixed, with the consensus rating at Hold and an average price target near $14.72. Notable recent actions include UBS raising its target to $17 with a Buy rating, while Wells Fargo maintained an Underweight rating with an $11 target.

Exploring Tickeron’s Trending AI Robots

For traders seeking data-driven approaches to navigate stocks like Ford, Tickeron’s Trending AI Robots page offers a curated view of AI-powered trading bots actively trading across thousands of tickers. Tickeron hosts hundreds of specialized bots, each employing distinct strategies, time horizons, and performance frameworks, but only the top-performing and most relevant ones rise to visibility in this section. Whether a trader favors short-term momentum plays, swing trading, or longer-horizon value rotations, the Trending AI Robots dashboard provides a snapshot of what AI-driven signals are prioritizing in real time. Exploring the page can help investors identify which algorithmic strategies are gaining traction in current market conditions. In my view, this kind of tool adds a useful layer when cross-checking traditional analysis.

2026 Outlook and What Investors Should Watch

The second half of 2026 presents a series of pivotal moments for Ford. The immediate focus falls on the July 28 Q2 earnings report, where investors will scrutinize management's commentary on F-Series production recovery, the pace of Novelis-related EBIT recapture, and any updates to full-year guidance. The consensus EPS estimate for Q2 stands at $0.34, with revenue expectations around $45.2 billion. I'm watching this closely as a potential inflection point.

Beyond earnings, Ford Energy's trajectory will remain a key swing factor. While the business is not expected to contribute materially to near-term earnings, progress on the 20 GWh capacity target and additional customer agreements could sustain investor interest in the AI-adjacent narrative. Meanwhile, Ford Pro's software subscription growth — up 30% year-over-year to 879,000 in Q1 — offers a recurring-revenue story that differentiates Ford from traditional automaker peers.

Macroeconomic variables also loom large. Interest rates, consumer credit conditions, and potential tariff policy shifts under the current administration could influence both vehicle affordability and Ford's cost structure. On the competitive front, Executive Chairman Bill Ford has publicly warned about accelerating pressure from Chinese EV manufacturers, signaling that the company views global EV competition as a long-term strategic challenge. How Ford balances its ICE, hybrid, EV, and energy storage investments against this backdrop will likely define the investment thesis through year-end.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: F

F in upward trend: 10-day moving average moved above 50-day moving average on July 30, 2026

The 10-day moving average for F crossed bullishly above the 50-day moving average on July 30, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where F advanced for three days, in of 324 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 257 cases where F Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for F moved out of overbought territory on July 30, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 33 similar instances where the indicator moved out of overbought territory. In of the 33 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on August 04, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on F as a result. In of 82 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for F turned negative on August 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at .

F moved below its 50-day moving average on August 03, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where F declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

F broke above its upper Bollinger Band on July 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating outstanding price growth. F’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.539) is normal, around the industry mean (9.096). P/E Ratio (11.838) is within average values for comparable stocks, (542.026). F's Projected Growth (PEG Ratio) (8.543) is very high in comparison to the industry average of (2.773). Dividend Yield (0.043) settles around the average of (0.038) among similar stocks. P/S Ratio (0.294) is also within normal values, averaging (11.068).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. F’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

Notable companies

The most notable companies in this group are Tesla (NASDAQ:TSLA), General Motors Company (NYSE:GM), Ford Motor Company (NYSE:F), NIO Inc. (NYSE:NIO).

Industry description

Automobiles continue to be arguably the most popular form of passenger travel in the U.S., and major automobile makers have revenues and market capitalizations running into multi-billions. In recent years, the industry has been experiencing some path-breaking innovations like electric vehicles and self-driving technology. While there are long-standing companies like General Motors, Ford, and Toyota Motors operating in this space, there are also emerging/rapidly growing players like Tesla – which has had a major role in the growing popularity of the electric vehicle market. With technological advancements taking steam in the auto space, we’ve also witnessed collaborations (or talks of potential partnerships) of carmakers with tech behemoths like Google’s subsidiary, Waymo.

Market Cap

The average market capitalization across the Motor Vehicles Industry is 61.15B. The market cap for tickers in the group ranges from 3.72K to 1.27T. TSLA holds the highest valuation in this group at 1.27T. The lowest valued company is ZAPPF at 3.72K.

High and low price notable news

The average weekly price growth across all stocks in the Motor Vehicles Industry was -3%. For the same Industry, the average monthly price growth was -5%, and the average quarterly price growth was -22%. SEV experienced the highest price growth at 19%, while LVWR experienced the biggest fall at -46%.

Volume

The average weekly volume growth across all stocks in the Motor Vehicles Industry was -26%. For the same stocks of the Industry, the average monthly volume growth was -24% and the average quarterly volume growth was -64%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 55
P/E Growth Rating: 58
Price Growth Rating: 64
SMR Rating: 93
Profit Risk Rating: 92
Seasonality Score: 9 (-100 ... +100)
View a ticker or compare two or three
F
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a manufacturer of automobiles and trucks

Industry MotorVehicles

Profile
Details
Industry
Motor Vehicles
Address
One American Road
Phone
+1 313 322-3000
Employees
177000
Web
https://www.ford.com
Interact to see
Advertisement
Novartis (NVS) reports Q4/FY 2025 earnings on February 4, 2026, with consensus calling for ~$1.99 EPS on ~$13.7 billion in revenue. Sanofi (SNY) delivered strong FY 2025 results on January 29, reporting €43.6 billion in sales (+9.9% CER) and 15% business EPS growth.
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
MUFG is expected to report Q3 FY2026 EPS of about $0.30, broadly in line with its recent pattern of earnings beats.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
CME Group (CME): Q4 2025 earnings due February 4, 2026; consensus expects adjusted EPS $2.75 and revenue ~$1.6B. S&P Global (SPGI): Q4 2025 earnings due February 10, 2026; Q3 posted EPS $4.73 and 9% revenue growth, driven by Ratings, Indices, and Market Intelligence.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.